Artificial intelligence
Lunit to export breast cancer detecting solutions to Hong Kong, Mongolia
The S.Korea's medical imaging startup hopes to expand sales of AI breast cancer diagnosis solutions in East Asian countries
By Dec 22, 2022 (Gmt+09:00)
1
Min read
Most Read
Alibaba eyes 1st investment in Korean e-commerce platform
Blackstone signs over $1 bn deal with MBK for 1st exit in Korea
OCI to invest up to $1.5 bn in Malaysia’s polysilicon plant
Korea's Lotte Insurance put on market for around $1.5 bn
NPS loses $1.2 bn in local stocks in Q1 on weak battery shares
South Korea's AI-based medical imaging equipment firm Lunit will export AI breast cancer diagnosis solutions to large hospitals in Hong Kong and Mongolia.
Lunit announced on Thursday that it has signed a contract to supply Lunit Insight MMG, an AI breast cancer screening solution, to Hong Kong Women's Imaging (HKWI), Hong Kong's largest diagnosis imaging center, and Mongolia's National Cancer Center.
Starting with this contract, the company expects to supply solutions to hospitals under the Hong Kong Hospital Authority, a Hong Kong public hospital management organization, and other hospitals in Mongolia.
"I hope this deal will serve as a bridgehead for entering East Asian countries such as China and Singapore," said Suh Beom-seok, CEO of Lunit.
Write to Jung-Eun Kim at likesmile@hankyung.com
More to Read
-
Bio & PharmaLunit exports AI imaging analysis solution to Brazil
Dec 19, 2022 (Gmt+09:00)
1 Min read -
Korean startupsHealthQuest-backed Lunit applies for 2022 Kosdaq IPO
Nov 30, 2021 (Gmt+09:00)
3 Min read -
Korean startupsHealthQuest picks Korea’s Lunit for first investment in Asia
Nov 24, 2021 (Gmt+09:00)
2 Min read
Comment 0
LOG IN